ACHL

ACHL


A New Era: Targeting Iron Deficiency to Improve Heart Failure Outcomes

Dive into the current and emerging diagnostic approaches to support iron deficiency (ID) as a treatment target for heart failure (HF) with a panel of experts. This activity features case discussions that demonstrate best practices in the clinical assessment and diagnosis of ID, as well as its management in patients with HF to improve awareness around “medical misses” for optimal patient outc...
ACHL

A New Path Forward: The Therapeutic Potential of Next Generation BTK Inhibitors in CLL/SLL

Targeted agents such as Bruton tyrosine kinase (BTK) inhibitors dramatically changed the treatment landscape for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Unfortunately, challenges with tolerance and resistance are pervasive with these agents. Novel highly selective, non-covalent (reversible) BTK inhibitors that may overcome these challenges are undergoing investigatio...
The University of Texas MD Anderson Cancer Center

All in for ALL: Mitigating VOD Risk in Patients Being Treated for R/R ALL

Are you involved with mitigating veno-occlusive disease (VOD) risk in patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)? Are you current with the latest guidance regarding R/R ALL treatment? The therapeutic landscape for R/R ALL now comprises of a wide variety of agents. Stay abreast of the most recent R/R ALL treatment updates as well as the latest in how to manage VOD ri...
University of Chicago Pritzker School of Medicine

Are You Ready? DOACs for Pediatric Patients with Venous Thromboembolism

In this CME Touchpoint, leading pediatric cardiology expert, Riten Kumar, MD, MSc highlights the latest data on pediatric VTE and the role of DOACs. This interactive, engaging newsletter also expresses relevant dosing and administration considerations with the DOACs in the pediatric population. Clinicians need to stay abreast of the latest data with the DOACs in pediatric patients with or at ...
ACHL

Beyond the Procedure: Evolving the Current Standard of Care for Patients with PAD

In three fast-paced modules, a multispecialty panel of cardiology, radiology, and vascular surgery experts provide perspectives on preventing adverse limb events in patients undergoing revascularization. Vascular medicine expert Dr. Anahita Dua moderates these brief discussions and case presentations with a focus on the latest clinical trial data and implications for patient care.
ACHL

Breaking the Cycle: The Role of Microbiota-Based Biotherapies in the Reduction of Recurrent Clostridioides difficile

Drs. Paul Feuerstadt, Sahil Khanna, Teena Chopra and Caterina Oneto convened at annual gastroenterology and infectious disease congresses to discuss clinical scenarios and best practices to manage recurrent Clostridioides difficile (C. difficile) infections; this activity chronicles their discussions. Tune in for updates on risk factors and prevention strategies for recurrent infection, as well ...
ACHL

CME Brief: Clinical Insights on Monkeypox

The multi-country outbreak of monkeypox is now a global health emergency. Infections are being identified in areas where the virus is not usually found, and the transmission and presentation are following atypical patterns. In this activity, Dr. Joseph Osmundson discusses the current outbreak encompassing recognition, diagnosis, prophylactic strategies, and available treatments. Up-to-date resou...
ACHL

Collaborative Management Strategies for Acute/Urgent Care in Short Bowel Syndrome

Patients with short bowel syndrome (SBS) may present in an acute care setting for many reasons, including diarrhea, dehydration, bowel obstruction, gallstones, and complications related to parenteral nutrition (PN) such as infections. In this Clinical Commentary video with accompanying downloadable infographic, physicians, nurses, NPs, and PAs within the urgent care and emergency department sett...
Rush University Medical Center

Community Conversations: Real-World Strategies for Overcoming Disparities in Immunotherapy Cancer Care

These powerful and captivating stories follow real-world patients on their immunotherapy journeys. Multidisciplinary cancer care clinicians also provide insightful perspectives on these stories. Experts review the latest data and guidance to frame ongoing disparities with immunotherapy access and share strategies to overcome barriers and broaden therapeutic opportunities for underserved patien...
ACHL

Diagnosing and Treating Women with IDA: What Every Clinician Needs to Know

Are you a clinician who treats women at risk of iron deficiency (ID)/iron deficiency anemia (IDA)? Are you aware of the risk factors, the causes, and the clinical implications of ID/IDA in women? Do you know any screening tools to support timely diagnosis and optimal treatment selection for ID/IDA? Access this short, animated whiteboard to learn the best practices for clinical management of ID/I...
ACHL

Diagnostic Pathways for Alzheimer Disease: Optimizing Multidisciplinary Practices

Alzheimer disease (AD) is associated with a significant and increasing burden for patients, their caregivers, and society as the population ages. This activity has been designed with differing educational pathways for specialists and nonspecialists to address the needs of their clinical practices, and will help clinicians identify and differentiate AD from normal aging and other neurocognitive d...
ACHL

Differentiating Early Signs of Alzheimer Disease From Normal Signs of Aging and Determining Best Next Steps.

Join us for this in-depth look at the early diagnosis of Alzheimer disease. Dr. James Galvin presents ways to differentiate Alzheimer disease from other neurodegenerative disorders, implement appropriate testing methods for earlier detection, and apply recent evidence to treatment selection to optimize patient outcomes.
ACHL

Early-Stage TNBC: What are the Roles of PARPIs?

Explore the latest groundbreaking treatment approaches for early-stage triple-negative breast cancer (TNBC) in this engaging tumor board! The multidisciplinary panel of expert faculty will dive into a case involving a patient with early TNBC and discuss the latest data and potential roles of PARP inhibitors (PARPIs) in the first CME activity offered in this TNBC series. TNBC is an aggressive...
ACHL

Emerging Strategies for Optimizing and Simplifying the Management of Resistant Hypertension

Delve into emerging therapies for resistant hypertension in this symposium highlights video. Hear from a multidisciplinary panel of experts discussing the current state of evaluation, diagnosis, and management of resistant hypertension, along with the challenges faced by clinicians. A patient case study and panel discussion provide practical advice for improving patient outcomes within the evolv...
ACHL

Ensuring Gender-Affirming Health Care for Transgender and Gender-Diverse Youth

Transgender youth see higher rates of suicide, poorer health outcomes, and an overall lack of access to quality care. In this expert interview, join pediatrician and child psychiatrist, Jason Rafferty, MD, MPH, EdM, from the Warren Alpert Medical School of Brown University, on a path to ensuring equitable and comprehensive healthcare for transgender and gender diverse youth. Ensure your transgen...
ACHL

Eosinophilic Esophagitis (EoE) Essentials for the Multidisciplinary Provider Team

The current standard of care for patients with EoE is suboptimal and often achieves only limited relief of symptoms. However, an approved therapy is now available and novel therapeutic options continue to be evaluated as management of this disease evolves rapidly. This self-paced, interactive education includes a personalized learning assessment that is designed to sharpen your knowledge and com...
Purdue University College of Pharmacy

Evolving Recommendations and Strategies for Vaccine Selection in Populations at Risk for Severe Influenza-related Illness

Are you current with the recent data and guidance on influenza vaccine selection based on age, risk factors, and individual characteristics? Do you know about the most recently approved and emerging vaccines? Access this comprehensive 60-minute, CME Touchpoint that will walk you through an overview of novel and emerging influenza vaccines and their potential roles in preventative medicine. This ...
ACHL

Expanding the Benefit of Quality Improvement Programs to Diverse Provider Types: Practical Solutions to Prevent and Prepare for Severe Hypoglycemia

Using a simple, systematic approach for quality improvement, for application at any practice setting, from the hospital to the private primary care practice to the community pharmacy, we provide the framework and tools you need to help your patients prevent, recognize, and manage hypoglycemic events.
ACHL

Exploring Emerging Therapeutic Opportunities for Menopausal Women with Autoimmune Disease

Expert endocrinologist Ekta Kapoor, MBBS, and leading rheumatologist, Mehret Birru Talabi, MD, PhD, discuss the menopause experience for women with autoimmune conditions including the risks associated with hormone replacement therapy (HRT) in antiphospholipid (aPL)-positive patients, recommended management of vasomotor symptoms (VMS) with concomitant autoimmune diseases, and the potential with e...
ACHL

Get It Right the First Time: Selection of Antimicrobial Therapy for C. difficile

This CME Touchpoint digital newsletter is a great way to bring clinicians up to date on the guideline recommendations for the selection of antimicrobial therapy when treating initial and recurrent C. difficile infection. Dr. Feuerstadt and Dr. Khanna review the latest clinical trial data and treatment guidelines for C. difficile infection. The digital newsletter includes text-based content, fac...
ACHL

Hard to Swallow, Pharmacist-Led Strategies to Improve EoE Care

As the prevalence of eosinophilic esophagitis (EoE) continues to increase, pharmacists can play a pivotal role in its recognition, diagnosis, and recommendations for management. In this activity Dr. Gary Falk, a gastroenterologist, and pharmacists Dr. Brian Hemstreet and Dr. Hamai Tom discuss advances in EoE and the clinical implications of available and emerging therapies in long-term manageme...
ACHL

Highlights in FSGS and IgAN

Dr. Jai Radhakrishnan explores data on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) from a recent nephrology meeting in this brief interview-style video. Dr. Radhakrishnan discusses emerging data on the pathophysiology and treatment of FSGS and IgAN in addition to the clinical implications of these advances. Focal segmental glomerulosclerosis and IgAN are glomerular di...
ACHL

Individualizing Prostate Cancer Treatment: Special Considerations for Gay and Bisexual Men

This activity features a panel consisting of an oncologist and leading experts (a urologist and a researcher) in prostate cancer care considerations in gay and bisexual men (GBM), where they discuss quality of life considerations and disparities. The panel’s aim is to provide clinicians with real-world strategies to facilitate optimal communication and shared decision-making with these patient...
ACHL

Initial Therapy Matters for Clostridioides difficile " Get it Right the First Time

Never miss a diagnosis of Clostridioides difficile (C. difficile) infection again! This engaging activity features a dive into the diagnosis and treatment of community-acquired C. difficile infection with a multidisciplinary expert panel in a roundtable discussion. In this one-of-a-kind educational experience, a captivating moderator leads a team of 3 physicians from internal medicine, infectiou...
ACHL

Keeping Up the Pace in IBD: Adaptive Learning to Optimize Therapeutic Decision-Making for Patients with UC and CD

Whether you’re a specialist looking for advanced-level learning around optimally managing Crohn’s disease and ulcerative colitis, a generalist needing to expand your knowledge of inflammatory bowel disease (IBD), or an allied healthcare professional wanting to support patients, don’t miss the opportunity to participate in this one-of-a-kind educational experience. In this adaptive learning...
ACHL

Latest Data in FSGS and IgAN

Expert faculty, Dr. Richard Lafayette, explores clinical trial data coming out of a recent nephrology meeting, and provides learners with up-to-date knowledge on focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). This brief interview-style video offers insights into the patient burden of chronic kidney disease, advances in understanding the pathophysiology, and emerging approa...
ACHL

Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago Race, Ethnicity, and Breast Cancer: Screening and Diagnosis

This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County. In this worksho...
University of Chicago Pritzker School of Medicine

Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago Race, Ethnicity, and Breast Cancer: Treatment

This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County. In this worksho...
University of Chicago Pritzker School of Medicine

Lessons Learned and New Opportunities: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in Prostate Cancer

This interactive tool is interspersed with videos of leading experts in prostate cancer disparities research. The materials and resources provided in this activity help learners become better able to identify systemic, behavioral, and sociocultural variables that continue to contribute to prostate cancer inequities. The experts in this activity provide insights and resources for learners to help...
ACHL

LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery

In this, 60-minute activity, expert faculty review recommendations for the treatment of major depressive disorder (MDD), case vignettes, and “How I Do It” best practices. Discussions focus on the impact of measurement-based care for tracking symptoms of depression; assessment and management of treatment-related emotional blunting; as well as, strategies on how to involve patients in shared d...
ACHL

LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery (Patient Whiteboard)

LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery (Patient Whiteboard) is a brief whiteboard animation developed to provide patients with the right information to achieve full functional recovery and find your light again. Learn strategies on: • the signs, symptoms, and causes of emotional blunting • how to recognize when your...
ACHL

Menopause Matters…Let’s Start Paying Attention to Racial and Ethnic Differences.

This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic backgrounds. Faculty discussion covers overcoming these disparities, guideline recommendations, a novel mechanism for controlling vasomotor symptoms, and strategies to educate patients. First-hand patient testimonials complement the discussion.
ACHL

Multidisciplinary Viewpoints on NTM-LD Diagnosis and Management

In two virtual roundtables, a pulmonologist, infectious disease specialist, and clinical pharmacist share their experiences in addressing challenges in diagnosing and treating patients with NTM-LD. The expert panel discusses strategies for expediting diagnosis and improving patient care and outcomes within the context of a patient’s reflections on the path to diagnosis and their treatment expe...
ACHL

New Possibilities for Maintenance Therapy in AML

A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr. Roboz present 3 cases with particular attention to and discussion of risks of relapse in AML, the role of maintenance therapy, and shared decision-making to engage patients in discussions surrounding maintenance therapy. The role of maintenance treatment in AML care has ...
ACHL

Next Generation Pneumococcal Vaccines: What You Need to Know

What’s new with pneumococcal vaccines? In 2021, two exciting, next-generation pneumococcal vaccines have become available. Expert faculty from Loma Linda University, the University of Pittsburgh School of Medicine, and the Lewis Katz School of Medicine at Temple University recently led a symposium at a major internal medicine meeting outlining the characteristics and latest recommendations wit...
ACHL

Next Generation Pneumococcal Vaccines: What You Need to Know

What’s new with pneumococcal vaccines? In 2021, two exciting, next-generation pneumococcal vaccines have become available. Expert faculty from Loma Linda University, the University of Pittsburgh School of Medicine, and the Lewis Katz School of Medicine at Temple University recently led a symposium at a major internal medicine meeting outlining the characteristics and latest recommendations wit...
ACHL

Pathways to Transfusion Independence & Reduced Health Complications: Advances for Lower-Risk MDS

In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience to establish optimal recognition, diagnostic, and treatment practices, and discuss opportunities for shared decision making with patients. Learners are questioned about how they would proceed at different clinical decision points, and faculty commentaries offer ...
ACHL

Patient-Centered Approaches to Treatment and Prevention of Clostridioides difficile Infection

Listen in as two patients share their experiences with treatment for C. difficile and its recurrence. In this short webisode Dr. Paul Feuerstadt and Dr. Sahil Khanna discuss fresh insights and strategies for selecting treatment of CDI in real-world settings. The Centers for Disease Control and Prevention continues to classify C. difficile as an urgent threat given the great burden on patients...
ACHL

Practical Solutions to Prevent and Prepare for Severe Hypoglycemia

Episodes of hypoglycemia, including those that are severe, still occur despite new pharmacotherapies and the increased use of continuous glucose monitoring. Do you know which of your patients are at risk? Are they prepared with an active glucagon prescription? This activity helps you identify at risk patients and ensure they are prepared with access to glucagon. Included with the education are t...
ACHL

Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC

Despite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American and Hispanic patients, face inequities with access to these health breakthroughs. In this activity, expert faculty focus on the latest evidence with NSCLC disparities of care and how to best overcome these barriers. The activity also reviews how t...
Rush University Medical Center

Race, Ethnicity, and Breast Cancer: Health Equity Panel Discussion

This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County. In this panel d...
University of Chicago Pritzker School of Medicine

Ready, Set, Action: Collaborative Management to Improve Diagnosis of Alzheimer Disease

It can be a struggle to diagnose Alzheimer disease (AD), but it is worth the time and effort! The benefits of a timely diagnosis for both patients and families cannot be overstated. Do you have questions about appropriate tests you can use in daily practice? Do you do cognitive, imaging, and/or biomarker tests when you suspect AD? Do you sometimes wonder how to talk about AD and diagnostic tests...
ACHL

Recurring Problems, New Solutions: Interrupting the Cycle of Recurrence in Clostridioides difficile Infection

Symposium highlights from a live session at a national conference where C. diff experts, Dr. Paul Feuerstadt, Dr. Kevin Garey, and Dr. Carolyn Alonso present a variety of patient cases highlighting how to best interrupt the cycle of CDI recurrence. Faculty also discuss the risks of recurrence as well as current guidelines for CDI treatment and prevention. View the patient cases and expanded ins...
ACHL

Shots in the Dark: How Can Clinicians Bridge the Immunization Gaps Widened by the COVID-19 Pandemic?

How can we bridge current immunization gaps further widened by the COVID-19 pandemic? Leading HPV and pneumococcal vaccine experts come together in this round-table discussion to share their experiences and strategies to increase vaccination rates. Additionally, faculty discuss the safety and efficacy data with the latest HPV and pneumococcal conjugate vaccine approvals.
ACHL

Showing Patients with Migraine the Possibilities with CGRP mAbs

This activity focuses on the latest data with calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) as well as personalized migraine treatment. Leading migraine experts, Jessica Ailani, MD, FAHS, FAAN and Richard Wenzel, PharmD discuss factors that influence treatment, strategies to improve therapeutic adherence, and comprehensive care strategies. To accompany this education, a sh...
ACHL

Sounding the Alarm: Protecting PAD Patients Post Revascularization from Recurrent Events

Listen to this engaging discussion on the latest evidence for patients with peripheral artery disease (PAD) post-revascularization! Several interactive case presentations are covered by our expert cardiology and vascular surgeon faculty. Topics include the latest data, clinical implications, unanswered questions, and potential outcomes with the latest approaches for mitigating recurrent events i...
ACHL

Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer-and Chemotherapy-Induced Anemia

This quick, comprehensive video will review the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics will discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and mana...
ACHL

T2D Management in Primary Care Practice: Addressing the Weight of it All

This expert-led activity offers a “how to” method for introducing strategies that support management of both dysglycemia and obesity. This activity highlights the ramifications of untreated obesity in patients with dysglycemia to underscore the importance of early obesity intervention. It also outlines ways to individualize obesity and dysglycemia management, recognize the benefits of earlie...
ACHL

TNBC Case Challenges. Test Your Treatment Skills!

Can you make optimal treatment choices for challenging triple-negative breast cancer (TNBC) cases? Put your TNBC skills to the test in these interactive case challenges. As the third and final activity in the TNBC series, you will navigate through two cases. Education is built into the cases, on practical strategies to meet the treatment needs of diverse patients with TNBC.
ACHL

Where do Anti-TROP2 ADCs Factor into Advanced TNBC Care?

Dive into additional groundbreaking treatment approaches for triple-negative breast cancer (TNBC) in this tumor board, the second in a series focused on TNBC. This multidisciplinary tumor board discusses a patient with advanced TNBC and how novel anti-TROP2 antibody drug conjugates (ADCs) therapy may play a role.
ACHL

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map